XML 85 R67.htm IDEA: XBRL DOCUMENT v3.7.0.1
Intangible Assets (Narrative) (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 07, 2016
USD ($)
Feb. 29, 2016
USD ($)
Sep. 03, 2014
USD ($)
brand
Dec. 31, 2016
USD ($)
Aug. 31, 2016
USD ($)
Dec. 31, 2014
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2016
USD ($)
Sep. 30, 2016
USD ($)
Jun. 30, 2016
USD ($)
Mar. 31, 2017
USD ($)
brand
Mar. 31, 2016
USD ($)
Mar. 31, 2015
USD ($)
acquisition
Jan. 26, 2017
USD ($)
Feb. 05, 2016
USD ($)
Apr. 30, 2014
USD ($)
Schedule of Intangible Assets [Line Items]                                
Number of business acquisitions | acquisition                         2      
Proceeds from divestitures                     $ 110,717,000 $ 0 $ 18,500,000      
Loss on divestitures             $ 268,000 $ (3,405,000) $ (496,000) $ 55,453,000 51,820,000 0 0      
Gain on sale of asset                     0 0 1,133,000      
Impairment of intangible assets                     $ 0          
Reporting unit, fair value in excess of carrying amount (percent)             53.00%       53.00%          
Number of indefinite-lived trade names exceeding carrying value by less than 10% | brand                     2          
Finite-lived intangible assets, weighted average remaining period                     13 years 4 months 24 days          
Amortization of intangible assets                     $ 19,753,000 18,430,000 12,995,000      
Minimum                                
Schedule of Intangible Assets [Line Items]                                
Intangible assets, useful lives                     10 years          
Maximum                                
Schedule of Intangible Assets [Line Items]                                
Intangible assets, useful lives                     30 years          
Painstop brand                                
Schedule of Intangible Assets [Line Items]                                
Intangible assets, useful lives   10 years                            
Indefinite-lived intangibles, reclassifications   $ 2,100,000                            
Insight Pharmaceuticals Corporation                                
Schedule of Intangible Assets [Line Items]                                
Intangible assets acquired     $ 724,374,000                          
Number of brands sold | brand     1                          
Insight Pharmaceuticals Corporation | One Brand Acquired from Insight subsequently sold                                
Schedule of Intangible Assets [Line Items]                                
Intangible assets acquired     $ 17,700,000                          
Hydralyte                                
Schedule of Intangible Assets [Line Items]                                
Intangible assets acquired                               $ 73,580,000
DenTek Oral Care, Inc.                                
Schedule of Intangible Assets [Line Items]                                
Intangible assets acquired                             $ 206,700,000  
C.B. Fleet Company, Inc.                                
Schedule of Intangible Assets [Line Items]                                
Intangible assets acquired                           $ 747,600,000    
Trademarks                                
Schedule of Intangible Assets [Line Items]                                
Indefinite-lived intangibles, reductions         $ 9,000,000                      
Indefinite Lived Trademarks                                
Schedule of Intangible Assets [Line Items]                                
Indefinite-lived intangibles, reductions                     $ 77,248,000   9,548,000      
Reporting unit, fair value in excess of carrying amount (percent)             40.80%       40.80%          
Indefinite-lived intangibles, reclassifications                     $ 2,064,000 $ 32,918,000 $ 46,506,000      
Beano Brand                                
Schedule of Intangible Assets [Line Items]                                
Reporting unit, fair value in excess of carrying amount (percent)             9.00%       9.00%          
Indefinite-lived intangible assets             $ 78,400,000       $ 78,400,000          
Fair value input, discount rate                     9.50%          
Decrease in annual cash flows, percent                     (8.30%)          
Increase in discount rate                     0.60%          
Comet Brand                                
Schedule of Intangible Assets [Line Items]                                
Proceeds from the sale of property and equipment         11,000,000 $ 10,000,000                    
Agreement election amount per quarter                   $ 1,000,000            
Gain on sale of asset         $ 1,200,000                      
Reporting unit, fair value in excess of carrying amount (percent)             9.00%       9.00%          
Indefinite-lived intangible assets             $ 101,300,000       $ 101,300,000          
Fair value input, discount rate                     9.50%          
Decrease in annual cash flows, percent                     8.20%          
Increase in discount rate                     0.70%          
Disposal group, disposed of by sale, not discontinued operations | North American OTC Healthcare                                
Schedule of Intangible Assets [Line Items]                                
Loss on divestitures                     $ 51,800,000          
Disposal group, disposed of by sale, not discontinued operations | Pediacare, New Skin and Fiber Choice | North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal products group                                
Schedule of Intangible Assets [Line Items]                                
Consideration, excluding costs of inventory $ 40,000,000                              
Proceeds from divestitures 40,100,000                              
Indefinite-lived intangibles, reductions 37,200,000                              
Finite-lived intangible assets, written off 54,000,000                              
Loss on divestitures $ 56,146,000                   $ 56,146,000          
Disposal group, disposed of by sale, not discontinued operations | Dermoplast | North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal products group                                
Schedule of Intangible Assets [Line Items]                                
Proceeds from divestitures       $ 48,400,000                        
Indefinite-lived intangibles, reductions       31,000,000                        
Disposal group, disposed of by sale, not discontinued operations | E.P.T. | North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal products group                                
Schedule of Intangible Assets [Line Items]                                
Indefinite-lived intangibles, reductions       $ 14,800,000